{"abstract": "Valeant Pharmaceuticals International offered to buy Cephalon for $5.7 billion in cash on Tuesday, kicking off a hostile bid for its smaller competitor after weeks of discussions failed to produce a deal.", "web_url": "https://dealbook.nytimes.com/2011/03/29/valeant-makes-5-7-billion-hostile-bid-for-cephalon/", "snippet": "Valeant Pharmaceuticals International offered to buy Cephalon for $5.7 billion in cash on Tuesday, kicking off a hostile bid for its smaller competitor after weeks of discussions failed to produce a deal.", "lead_paragraph": "8:12 p.m. | Updated ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Valeant Makes $5.7 Billion Hostile Bid for Cephalon", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Cephalon Incorporated", "rank": 1, "major": "N"}], "pub_date": "2011-03-29T22:23:49+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/a08b4271-8f98-58d7-8748-8a898952b2b6", "word_count": 435, "uri": "nyt://article/a08b4271-8f98-58d7-8748-8a898952b2b6"}